Form 4: Heartflow CFO's Equity Grant and Tax Withholding

Heartflow's Chief Financial Officer, Vikram Verghese, reported the acquisition of restricted stock units and stock options, alongside a disposition of shares for tax obligations.

Summary

• Vikram Verghese, Chief Financial Officer of Heartflow, Inc. (HTFL), reported changes in his beneficial ownership of company securities.
• Disposed of 542 shares of Common Stock at a price of $27.74 per share to cover income tax withholding and remittance obligations related to previously vested restricted stock units.
• Acquired 68,493 Restricted Stock Units (RSUs) with a vesting commencement date of February 6, 2026. These RSUs will vest 1/16th on each quarterly anniversary of the vesting commencement date, subject to continued service.
• Acquired 119,685 Stock Options with an exercise price of $27.74. These options vest 1/48th on each monthly anniversary of the vesting commencement date (February 6, 2026), subject to continued service, and expire on February 6, 2036.
• Following these transactions, Mr. Verghese beneficially owns 212,863 shares of Common Stock and 119,685 Stock Options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that align management incentives with shareholder value, without indicating any immediate operational or financial shifts for the company.

Positives

• The Chief Financial Officer received a significant grant of 68,493 Restricted Stock Units and 119,685 Stock Options, aligning his interests with long-term shareholder value.
• The equity grants demonstrate ongoing commitment and incentive for key management personnel.

Negatives

• A disposition of 542 shares of Common Stock occurred to satisfy tax withholding obligations, which is a standard practice upon RSU vesting and not indicative of a negative outlook.

Future Outlook

The filing details future vesting schedules for the granted Restricted Stock Units (1/16th quarterly from February 6, 2026) and Stock Options (1/48th monthly from February 6, 2026), subject to continued service.

Industry Context

StockSavvy.ai notes that these transactions represent routine executive compensation in the form of equity grants, a common practice across the healthcare technology sector to incentivize long-term performance and align management interests with shareholders.

Stakeholder Impact

• Shareholders: The equity grants align the Chief Financial Officer's financial interests with the long-term performance of the company, potentially fostering greater commitment to shareholder value creation.

Next Steps

• The acquired Restricted Stock Units will begin vesting 1/16th on each quarterly anniversary of February 6, 2026.
• The acquired Stock Options will begin vesting 1/48th on each monthly anniversary of February 6, 2026.

Key Dates

Keywords

Heartflow, HTFL, Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, RSU, Stock Options, Executive Compensation, CFO